PF-Atlas › Исследования › TGF-β Signaling
Исследования: TGF-β Signaling (32)
32 публикаций в теме «TGF-β Signaling», проиндексированных PF-Atlas из PubMed и мировых журналов.
- Orcinol glucoside ameliorates pulmonary fibrosis by suppressing hyaluronic acid synthesis and macrophage M2 polarization via targeting hyaluronic acid synthase 2. · International journal of molecular medicine · 2026
- BCL9 inhibition promotes fibroblast lipogenesis by regulating macrophage-fibroblast interactions to attenuate pulmonary fibrosis. · Signal transduction and targeted therapy · 2026
- LGMN promotes crosstalk between macrophages and fibroblasts in pulmonary fibrosis: a potential therapeutic target. · Frontiers in immunology · 2026
- Transcriptomic signatures of IPF in ALI-cultured airway cells and their therapeutic implications. · Thorax · 2026
- Sacubitril/valsartan as a modulator of pulmonary fibrosis: insights into Lnc-SNHG-16/miR-455 modulation and Notch/Smad-3 pathway inhibition. · Naunyn-Schmiedeberg's archives of pharmacology · 2026
- Natural compound 5,7,8‑trimethoxyflavone mitigates radiation‑induced lung injury by suppressing EMT and PI3K/Akt pathway. · International journal of molecular medicine · 2026
- Vitamin D attenuates the progression of pulmonary fibrosis via inhibiting thymidine kinase 1/PFKFB3-driven glycolysis. · Journal of translational medicine · 2026
- Epigallocatechin gallate targets the hexokinase 2-voltage-dependent anion channel 1 axis in myofibroblasts to attenuate pulmonary fibrosis. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- Transcription factor ID3 promotes fibroblast differentiation and proliferation in lung fibrosis through augmenting the TGF-β signaling pathway. · Molecular immunology · 2026
- Supplementation of αKG along with TGFβ/HIF1α antagonist rescues lung fibrosis in mice with severe SARS-CoV-2 infection. · Journal of translational medicine · 2026
- Nerandomilast, a PDE4B inhibitor, alleviates silica-induced lung inflammation and fibrosis by inhibition of NLRP3 inflammasome and TGF-β/Smad signalling. · British journal of pharmacology · 2026
- Targeting thrombin with hirudin alleviates paraquat-induced pulmonary fibrosis via the PAR-1-mediated TGF-β1 pathway. · Histology and histopathology · 2026
- Myocardial Fibrosis in Pediatric Heart Disease: Mechanisms, Imaging Biomarkers, Clinical Consequences, and Emerging Antifibrotic Therapies. · Cardiology in review · 2026
- Dapagliflozin Beyond Glucose Lowering: Mechanisms of Renal and Systemic Protection. · Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
- HSP90 Inhibitor, AT13387 Mitigates Chronic Lung Injury in Pre-Pubertal Mice: A Therapeutic Axis in Bronchopulmonary Dysplasia. · Biomolecules · 2026
- Research on the role and mechanism of SLC7A5 in idiopathic pulmonary fibrosis. · Molecular medicine reports · 2026
- Curcumin Improves Silica Induced Lung Fibrosis by Targeting TLR4-NLRP3 Inflammasome and TGF-β Inhibition in Mice Model. · Journal of biochemical and molecular toxicology · 2026
- Inhibition of runt related transcription factor 1 with Ro24-7429 improves lung function in experimental models of idiopathic pulmonary fibrosis. · Scientific reports · 2026
- Pharmacological repurposing of cilostazol to attenuate the progression of pulmonary fibrosis: efficacy validation via integrated network pharmacology and in vivo experimentation. · Naunyn-Schmiedeberg's archives of pharmacology · 2026
- From Inflammation to Precision Medicine: Mechanistic Insights into Asthma, COPD, and IPF. · Biomedicines · 2026
- Repurposing the MEK inhibitor binimetinib as a dual anti-inflammatory and antifibrotic agent in pulmonary fibrosis. · Journal of thoracic disease · 2026
- Subset binding enables detection of multimodal patient subgroup patterns and drug target discovery in idiopathic pulmonary fibrosis. · Briefings in bioinformatics · 2026
- Protective effect of nebivolol on bleomycin-induced lung fibrosis via suppressing TLR4/IL-1β/MMP-2 and TGF-β/HSP47 signaling pathways in rats. · Immunopharmacology and immunotoxicology · 2026
- A Lung-Targeted Carrier of Carbon Monoxide for Idiopathic Pulmonary Fibrosis Therapy. · ACS nano · 2026
- Inhalable TFRC-Targeted Extracellular Vesicles Delivery of siTGF-β1 Alleviates Pulmonary Fibrosis via Dual Inhibition of Ferroptosis and Fibroblast Activation. · International journal of nanomedicine · 2026
- Silibinin alleviates lung fibrosis by targeting Annexin A6 to suppress endoplasmic reticulum stress and oxidative stress. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- Berberine Ameliorates Pulmonary Fibrosis via Downregulating the TGFBR2-Mediated Signaling. · Chemical biology & drug design · 2026
- Nintedanib Lacks Efficacy in a Spirometry-Confirmed and Bleomycin-Induced Mouse Model of Idiopathic Pulmonary Fibrosis. · Basic & clinical pharmacology & toxicology · 2026
- Alveolar Epithelial Cell-Derived Exosomes Regulate Autophagy Through miR-450b-5p/HDAC7 to Improve Pulmonary Fibrosis. · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
- The intersection of liver cirrhosis and pulmonary fibrosis. · Journal of translational medicine · 2025
- TRIM2 exacerbates the advancement of idiopathic pulmonary fibrosis by modulating β-catenin and endoplasmic reticulum stress. · European journal of medical research · 2025
- Echinacea purpurea ameliorates Bleomycin-induced pulmonary fibrosis in rats through modulating NADPH oxidase-4 and endothelin-1/connective tissue growth factor/matrix metalloproteinases signalling axis. · Scientific reports · 2025
Медицинская оговорка. Списки исследований приведены только для информации и не являются медицинской рекомендацией.